Humacyte, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
HUMA, HUMAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2525 East North Carolina Highway 54, Durham, NC

Insiders trading volume in the past year

Humacyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ayabudge LLC 10%+ Owner $9.75M Aug 17, 2023
Laura E. Niklason President, CEO and Director, Director $8.38M -$27M -76.3% Jan 21, 2025
Brady W. Dougan Director $8.38M -$27M -76.3% Jan 21, 2025
Gordon M. Binder Director $1.41M +$668K +89.5% May 15, 2024
Max N. Wallace Director $406K +$50K +14.1% Jun 13, 2024
Kathleen Sebelius Director $120K +$38K +46.1% Apr 8, 2025
Dale A. Sander CFO and Chief Corp. Deve. Off. $65.2K -$233K -78.1% Apr 10, 2025
William Edward Tente Chief Regulatory Officer $62.5K Aug 26, 2021
Michael T. Constantino Director $41.5K +$59.8K Apr 7, 2025
William John Scheessele Chief Commercial Officer $33.9K +$10K +41.8% Apr 14, 2025
Shamik J. Parikh Chief Medical Officer $11.6K +$11.6K Apr 10, 2025
Charles Bruce Green Director $10.8K +$7.74K +250% Apr 8, 2025
Jeffrey Harold Lawson Chief Surgical Officer, Director $9.37K Aug 26, 2021
Heather Ledbetter Prichard Chief Operating Officer $0 -$1.56M -100% Jan 21, 2025
John Philip Bamforth Director Jun 13, 2024
Emery N. Brown Director Jun 13, 2024
Todd Pope Director Jun 13, 2024
Kiernan Thomas DeAngelis Chief Medical Officer Aug 26, 2021
Yang Cao Chief Regulatory Officer Jan 21, 2025
Diane Seimetz Director Jun 13, 2024
Rajiv Shukla Director Jun 15, 2023
Fresenius Medical Care Holdings Inc /Ny/ 10%+ Owner Aug 26, 2021
Susan Windham-Bannister Director Jun 13, 2024
Keith Anthony Jones Director Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for Humacyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.